Long-Term Treatment with Sodium Cromoglycate, Nedocromil Sodium and Beclomethasone Dipropionate Reduces Bronchial Hyperresponsiveness in Asthmatic Subjects
- 1 January 1992
- journal article
- clinical trial
- Published by S. Karger AG in Respiration
- Vol. 59 (2) , 97-101
- https://doi.org/10.1159/000196035
Abstract
165 patients (106 males, 59 females) entered an open group comparative study of a 12-week test treatment on bronchial hyperresponsiveness (BHR) determined by methacholine challenge. Patients were randomly allocated to receive nedocromil sodium (4 mg q.i.d.), sodium cromoglycate (10 μg q.i.d.) and beclomethasone dipropionate (500 μg t.i.d.). At the end of the study, an 2.25-fold increase of the PD20FEV1 was noted in all the treated patients. No significant difference was noted among the treatments.Keywords
This publication has 0 references indexed in Scilit: